Matches in Nanopublications for { ?s ?p "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 19 of
19
with 100 items per page.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1216762.RAeUtjI6ud69lwFLZvcIhVfB8DUq_bW_G-rhDSfXxbCI0130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216762.RAeUtjI6ud69lwFLZvcIhVfB8DUq_bW_G-rhDSfXxbCI0130_provenance.
- NP1216763.RAUg9rsxCPwqEwEHp-5PsdJmjHB17bmqTgEIQMCI5PL5g130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216763.RAUg9rsxCPwqEwEHp-5PsdJmjHB17bmqTgEIQMCI5PL5g130_provenance.
- NP1216766.RAdtXmUiljdNqGEgIBMpC3jfzmV66hePBPav_DFJhXMZo130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216766.RAdtXmUiljdNqGEgIBMpC3jfzmV66hePBPav_DFJhXMZo130_provenance.
- NP1216752.RAp8-IBiYAdQxWk19-HkzXDpJOVCoSNnJ_9RtxniqQPrw130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216752.RAp8-IBiYAdQxWk19-HkzXDpJOVCoSNnJ_9RtxniqQPrw130_provenance.
- NP1216753.RAscZvrTCW670JGknrKUyAZanAprmFwPBUJihF_b1CuLM130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216753.RAscZvrTCW670JGknrKUyAZanAprmFwPBUJihF_b1CuLM130_provenance.
- NP1216756.RAucnPimfldBoGW7ckpzrXkpqefslIU36em1at8X4W6Qw130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216756.RAucnPimfldBoGW7ckpzrXkpqefslIU36em1at8X4W6Qw130_provenance.
- NP1216761.RAl2VBPsMTTOzh4pPdvVv0V5jeNlKPKKAwvfv1iCfKYtQ130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216761.RAl2VBPsMTTOzh4pPdvVv0V5jeNlKPKKAwvfv1iCfKYtQ130_provenance.
- NP1216758.RAF6OwwdjBSYzDYmZwjCtJLn04asGzZIn3z8_eb9T3k48130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216758.RAF6OwwdjBSYzDYmZwjCtJLn04asGzZIn3z8_eb9T3k48130_provenance.
- NP1216757.RA3CTKvYIFQN8mvKV_7ZgE3tjny8oURvRtggj_ew84DD4130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216757.RA3CTKvYIFQN8mvKV_7ZgE3tjny8oURvRtggj_ew84DD4130_provenance.
- NP1216765.RA7pzW0XdmWKGFg7BFsvykhDknGuwAZNgzq0rN--XOGZE130_assertion description "[Copy-number variants and truncating mutations in SHANK genes were present in ?1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216765.RA7pzW0XdmWKGFg7BFsvykhDknGuwAZNgzq0rN--XOGZE130_provenance.